Meta-engineering in drug design: A roadmap to implement a novel liposome-based testbed

[1]  S. Jiang,et al.  Inhibition of HIV-1 infection by a fusion domain binding peptide from the HIV-1 envelope glycoprotein GP41. , 1993, Biochemical and biophysical research communications.

[2]  M. Kielian,et al.  Membrane fusion and the alphavirus life cycle. , 1995, Advances in virus research.

[3]  T. Matthews,et al.  Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P S Sarma,et al.  Viral interference in feline leukemia-sarcoma complex. , 1971, Virology.

[5]  P. E. Hotz,et al.  Towards Personalized Drug Delivery - Preparation of an Encapsulated Multicompartment System , 2018, BIODEVICES.

[6]  Kenichi Yoshikawa,et al.  Gene Expression within Cell‐Sized Lipid Vesicles , 2003, Chembiochem : a European journal of chemical biology.

[7]  P. E. Hotz,et al.  Multivesicular Assemblies as Real-World Testbeds for Embryogenic Evolutionary Systems , 2009, ACAL.

[8]  Ying Zhang,et al.  Artificial cells: building bioinspired systems using small-scale biology. , 2008, Trends in biotechnology.

[9]  W. B. Martin,et al.  Leukæmia in the Cat: A Virus-like Particle associated with Leukæmia (Lymphosarcoma) , 1964, Nature.

[10]  P. Luisi,et al.  Enzymatic RNA replication in self-reproducing vesicles: an approach to a minimal cell. , 1995, Biochemical and biophysical research communications.

[11]  E. Grell,et al.  Carriers and specificity in membranes. IV. Model vesicles and membranes. The formation of asymmetrical spherical lecithin vesicles. , 1971, Neurosciences Research Program bulletin.

[12]  G. Zubay,et al.  In vitro synthesis of protein in microbial systems. , 1973, Annual review of genetics.

[13]  P. Luisi,et al.  Protein expression in liposomes. , 1999, Biochemical and biophysical research communications.

[14]  J Overbaugh,et al.  Cloning of the cellular receptor for feline leukemia virus subgroup C (FeLV-C), a retrovirus that induces red cell aplasia. , 2000, Blood.

[15]  Mary Williard Elting,et al.  Rapid membrane fusion of individual virus particles with supported lipid bilayers. , 2007, Biophysical journal.

[16]  C. Tailor,et al.  A Putative Cell Surface Receptor for Anemia-Inducing Feline Leukemia Virus Subgroup C Is a Member of a Transporter Superfamily , 1999, Journal of Virology.

[17]  P S Kim,et al.  Mechanisms of viral membrane fusion and its inhibition. , 2001, Annual review of biochemistry.

[18]  Petra Schwille,et al.  Reconstitution and Anchoring of Cytoskeleton inside Giant Unilamellar Vesicles , 2008, Chembiochem : a European journal of chemical biology.

[19]  R. Huebner,et al.  Differential host range of viruses of feline leukemia-sarcoma complex. , 1975, Virology.

[20]  Jianbin Huang,et al.  Transition between Higher-Level Self-Assemblies of Ligand−Lipid Vesicles Induced by Cu2+ Ion , 2003 .

[21]  Horst Vogel,et al.  An integrated self-assembled nanofluidic system for controlled biological chemistries. , 2008, Angewandte Chemie.

[22]  Guillermo López,et al.  Feline Leukemia Virus and Other Pathogens as Important Threats to the Survival of the Critically Endangered Iberian Lynx (Lynx pardinus) , 2009, PloS one.

[23]  P. Luisi,et al.  Polymerase chain reaction in liposomes. , 1995, Chemistry & biology.

[24]  H. Stellbrink,et al.  Novel Compounds for the Treatment of HIV Type-1 Infection , 2009, Antiviral chemistry & chemotherapy.

[25]  Robert Bittman,et al.  Liposomes as target membranes in the study of virus receptor interaction and membrane fusion. , 2003, Methods in enzymology.

[26]  Aldo Jesorka,et al.  Liposomes: technologies and analytical applications. , 2008, Annual review of analytical chemistry.

[27]  P. E. Hotz,et al.  Towards Tailored Communication Networks in Assemblies of Artificial Cells , 2009, ACAL.

[28]  P S Sarma,et al.  Subgroup classification of feline leukemia and sarcoma viruses by viral interference and neutralization tests. , 1973, Virology.

[29]  J Overbaugh,et al.  The host range and interference properties of two closely related feline leukemia variants suggest that they use distinct receptors. , 1998, Virology.

[30]  Roberto Serra,et al.  Evolutionary experiments for self-assembling amphiphilic systems , 2008 .

[31]  Y Takeuchi,et al.  Feline leukemia virus subgroup B uses the same cell surface receptor as gibbon ape leukemia virus , 1992, Journal of virology.

[32]  Sophie Pautot,et al.  Engineering asymmetric vesicles , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Overbaugh,et al.  Feline leukemia virus T entry is dependent on both expression levels and specific interactions between cofactor and receptor. , 2007, Virology.

[34]  Kazufumi Hosoda,et al.  Quantitative study of the structure of multilamellar giant liposomes as a container of protein synthesis reaction. , 2008, Langmuir : the ACS journal of surfaces and colloids.

[35]  Paolo Rovero,et al.  Antiviral Activity and Conformational Features of an Octapeptide Derived from the Membrane-Proximal Ectodomain of the Feline Immunodeficiency Virus Transmembrane Glycoprotein , 2003, Journal of Virology.

[36]  J Overbaugh,et al.  Three distinct envelope domains, variably present in subgroup B feline leukemia virus recombinants, mediate Pit1 and Pit2 receptor recognition , 1997, Journal of virology.

[37]  Vincent Noireaux,et al.  Toward an artificial cell based on gene expression in vesicles , 2005, Physical biology.

[38]  A. Spirin,et al.  A continuous cell-free translation system capable of producing polypeptides in high yield. , 1988, Science.

[39]  E A Hoover,et al.  Feline leukemia virus infection and diseases. , 1991, Journal of the American Veterinary Medical Association.

[40]  J Overbaugh,et al.  Identification of a cellular cofactor required for infection by feline leukemia virus. , 2000, Science.

[41]  J. Overbaugh,et al.  Feline Pit2 Functions as a Receptor for Subgroup B Feline Leukemia Viruses , 2001, Journal of Virology.

[42]  Gary Richmond,et al.  A Controlled Phase Ii Trial Assessing Three Doses of Enfuvirtide (T-20) in Combination with Abacavir, Amprenavir, Ritonavir and Efavirenz in Non-Nucleoside Reverse Transcriptase Inhibitor-Naive HIV-Infected Adults , 2002, Antiviral therapy.

[43]  John S. McCaskill,et al.  Living Technology: Exploiting Life's Principles in Technology , 2010, Artificial Life.

[44]  Steen Rasmussen,et al.  Protocells : bridging nonliving and living matter , 2008 .

[45]  J. Overbaugh,et al.  A Putative Thiamine Transport Protein Is a Receptor for Feline Leukemia Virus Subgroup A , 2006, Journal of Virology.

[46]  Vincent Noireaux,et al.  A vesicle bioreactor as a step toward an artificial cell assembly. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[47]  Maik Hadorn,et al.  DNA-Mediated Self-Assembly of Artificial Vesicles , 2010, PloS one.

[48]  Y. Takeuchi,et al.  Porcine endogenous retrovirus and other viruses in xenotransplantation , 2009, Current opinion in organ transplantation.

[49]  O. Jarrett,et al.  Determinants of the host range of feline leukaemia viruses. , 1973, The Journal of general virology.

[50]  D. Hoekstra,et al.  Fluorescence assays to monitor fusion of enveloped viruses. , 1993, Methods in enzymology.

[51]  Jayne Lawrence,et al.  Eukaryotic integral membrane protein expression utilizing the Escherichia coli glycerol-conducting channel protein (GlpF) , 2007, Applied Microbiology and Biotechnology.

[52]  David W. Russell,et al.  The Condensed Protocols From Molecular Cloning: A Laboratory Manual , 2006 .